lidoflazine has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 1 studies
Lidoflazine: Coronary vasodilator with some antiarrhythmic action.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vliers, A | 1 |
| Stijns-Cailteux, M | 1 |
| Lintermans, J | 1 |
| Trémouroux-Wattiez, M | 1 |
| Godfraind, T | 1 |
1 other study available for lidoflazine and Cardiomyopathy, Hypertrophic Obstructive
| Article | Year |
|---|---|
[Severe hypertrophic myocardiopathy in newborn infants. Intra-erythrocyte calcium and the effect of lidoflazine, a calcium-channel inhibitor. Apropos of 2 cases].
Topics: Calcium; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Erythrocytes; Female; Humans; Infan | 1984 |